|
1
|
Kamada T, Haruma K, Ito M, Inoue K, Manabe
N, Matsumoto H, Kusunoki H, Hata J, Yoshihara M, Sumii K, et al:
Time trends in Helicobacter pylori infection and atrophic
gastritis over 40 years in Japan. Helicobacter. 20:192–198.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kinoshita Y, Kawanami C, Kishi K, Nakata
H, Seino Y and Chiba T: Helicobacter pylori independent
chronological change in gastric acid secretion in the Japanese.
Gut. 41:452–458. 1997.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fujiwara Y and Arakawa T: Epidemiology and
clinical characteristics of GERD in the Japanese population. J
Gastroenterol. 44:518–534. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bardhan KD: The role of proton pump
inhibitors in the treatment of gastro-oesophageal reflux disease.
Aliment Pharmacol Ther. 9 (Suppl 1):15–25. 1995.PubMed/NCBI
|
|
5
|
Chiba N, De Gara CJ, Wilkinson JM and Hunt
RH: Speed of healing and symptom relief in grade II to IV
gastroesophageal reflux disease: A meta-analysis. Gastroenterology.
112:1798–1810. 1997.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Soga T, Matsuura M, Kodama Y, Fujita T,
Sekimoto I, Nishimura K, Yoshida S, Kutsumi H and Fujimoto S: Is a
proton pump inhibitor necessary for the treatment of lower-grade
reflux esophagitis? J Gastroenterol. 34:435–440. 1999.PubMed/NCBI
|
|
7
|
Iwakiri K, Kinoshita Y, Habu Y, Oshima T,
Manabe N, Fujiwara Y, Nagahara A, Kawamura O, Iwakiri R, Ozawa S,
et al: Evidence-based clinical practice guidelines for
gastroesophageal reflux disease 2015. J Gastroenterol. 51:751–767.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Castell DO, Richter JE, Robinson M, Sontag
SJ and Haber MM: The Lansoprazole Group: Efficacy and safety of
lansoprazole in the treatment of erosive reflux esophagitis. Am J
Gastroenterol. 91:1749–1757. 1996.PubMed/NCBI
|
|
9
|
Kusano M, Shimoyama Y, Sugimoto S,
Kawamura O, Maeda M, Minashi K, Kuribayashi S, Higuchi T, Zai H,
Ino K, et al: Development and evaluation of FSSG: Frequency scale
for the symptoms of GERD. J Gastroenterol. 39:888–891.
2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Armstrong D, Bennett JR, Blum AL, Dent J,
De Dombal FT, Galmiche JP, Lundell L, Margulies M, Richter JE,
Spechler SJ, et al: The endoscopic assessment of esophagitis: A
progress report on observer agreement. Gastroenterology. 111:85–92.
1996.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kimura K and Takemoto T: An endoscopic
recognition of the atrophic border and its significance in chronic
gastritis. Endoscopy. 1:87–97. 1969. View Article : Google Scholar
|
|
12
|
Pilotto A, Franceschi M, Leandro G,
Scarcelli C, D'Ambrosio LP, Seripa D, Perri F, Niro V, Paris F,
Andriulli A, et al: Clinical features of reflux esophagitis in
older people: A study of 840 consecutive patients. J Am Geriatr
Soc. 54:1537–1542. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cho JH, Kim HM, Ko GJ, Woo ML, Moon CM,
Kim YJ, Han KJ, Song SY and Cho HG: Old age and male sex are
associated with increased risk of asymptomatic erosive esophagitis:
Analysis of data from local health examinations by the Korean
National Health Insurance Corporation. J Gastroenterol Hepatol.
26:1034–1038. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nagahara A, Hojo M, Asaoka D, Sasaki H,
Oguro M, Mori H, Matsumoto K, Osada T, Yoshizawa T and Watanabe S:
Clinical feature of asymptomatic reflux esophagitis in patients who
underwent upper gastrointestinal endoscopy. J Gastroenterol
Hepatol. 27 (Suppl 3):53–57. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Emerenziani S, Habib FI, Ribolsi M,
Caviglia R, Guarino MP, Petitti T and Cicala M: Effect of hiatal
hernia on proximal oesophageal acid clearance in gastro-oesophageal
reflux disease patients. Aliment Pharmacol Ther. 23:751–757.
2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Asaoka D, Nagahara A, Hojo M, Matsumoto K,
Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, et
al: Association of medications for lifestyle-related diseases with
reflux esophagitis. Ther Clin Risk Manag. 12:1507–1515.
2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jones MP, Sloan SS, Rabine JC, Ebert CC,
Huang CF and Kahrilas PJ: Hiatal hernia size is the dominant
determinant of esophagitis presence and severity in
gastroesophageal reflux disease. Am J Gastroenterol. 96:1711–1717.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jung SH, Oh JH and Kang SG: Clinical
characteristics and natural history of asymptomatic erosive
esophagitis. Turk J Gastroenterol. 25:248–252. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Haruma K, Kamada T, Kawaguchi H, Okamoto
S, Yoshihara M, Sumii K, Inoue M, Kishimoto S, Kajiyama G and
Miyoshi A: Effect of age and Helicobacter pylori infection
on gastric acid secretion. J Gastroenterol Hepatol. 15:277–820.
2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Fass R, Shapiro M, Dekel R and Sewell J:
Systematic review: proton pump inhibitor failure in
gastro-oesophageal reflux disease - where next? Aliment Pharmacol
Ther. 22:79–94. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hungin AP, Rubin G and O'Flanagan H:
Factors influencing compliance in long-term proton pump inhibitor
therapy in general practice. Br J Gen Pract. 49:463–464.
1999.PubMed/NCBI
|
|
22
|
Castell DO, Murray JA, Tutuian R, Orlando
RC and Arnold R: Review article: The pathophysiology of
gastro-oesophageal reflux disease - oesophageal manifestations.
Aliment Pharmacol Ther. 20 (Suppl 9):14–25. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Frazzoni M, De Micheli E, Zentilin P and
Savarino V: Pathophysiological characteristics of patients with
non-erosive reflux disease differ from those of patients with
functional heartburn. Aliment Pharmacol Ther. 20:81–88.
2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Annear MJ, Otani J and Sun J: Experiences
of Japanese aged care: The pursuit of optimal health and cultural
engagement. Age Ageing. 45:753–756. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Asaoka D, Nagahara A, Hojo M, Matsumoto K,
Ueyama H, Matsumoto K, Izumi K, Takeda T, Komori H, Akazawa Y, et
al: Efficacy of a potassium-competitive acid blocker for improving
symptoms in patients with reflux esophagitis, non-erosive reflux
disease, and functional dyspepsia. Biomed Rep. 6:175–180.
2017.PubMed/NCBI View Article : Google Scholar
|
